Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Asset Writedowns and Impairment (2016 - 2019)

Orthofix Medical (OFIX) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $1.0 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Asset Writedowns and Impairment rose 3778.57% year-over-year to $1.0 million, compared with a TTM value of $1.9 million through Dec 2019, up 415.69%, and an annual FY2022 reading of $2.1 million, up 371.85% over the prior year.
  • Asset Writedowns and Impairment was $1.0 million for Q4 2019 at Orthofix Medical, up from $223000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $5.6 million in Q1 2017 and bottomed at -$4.8 million in Q2 2017.
  • Average Asset Writedowns and Impairment over 4 years is $253000.0, with a median of $93000.0 recorded in 2016.
  • The sharpest move saw Asset Writedowns and Impairment crashed 2021.37% in 2017, then skyrocketed 3778.57% in 2019.
  • Year by year, Asset Writedowns and Impairment stood at $58000.0 in 2016, then surged by 44.83% to $84000.0 in 2017, then crashed by 133.33% to -$28000.0 in 2018, then surged by 3778.57% to $1.0 million in 2019.
  • Business Quant data shows Asset Writedowns and Impairment for OFIX at $1.0 million in Q4 2019, $223000.0 in Q3 2019, and $592000.0 in Q2 2019.